Wen-Ching Han

725 total citations
7 papers, 179 citations indexed

About

Wen-Ching Han is a scholar working on Organic Chemistry, Pharmacology and Oncology. According to data from OpenAlex, Wen-Ching Han has authored 7 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Wen-Ching Han's work include Inflammatory mediators and NSAID effects (2 papers), Phosphorus compounds and reactions (1 paper) and Synthesis and Characterization of Heterocyclic Compounds (1 paper). Wen-Ching Han is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Phosphorus compounds and reactions (1 paper) and Synthesis and Characterization of Heterocyclic Compounds (1 paper). Wen-Ching Han collaborates with scholars based in United States and Germany. Wen-Ching Han's co-authors include Gregory D. Vite, Brian E. Fink, Johnni Gullo-Brown, Chiang Yu, Joseph Fargnoli, R. M. Borzilleri, Barri Wautlet, John T. Hunt, Tai‐Tong Wong and Steven Mortillo and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Wen-Ching Han

7 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen-Ching Han United States 6 108 54 19 18 14 7 179
Tammy C. Wang United States 10 113 1.0× 98 1.8× 17 0.9× 11 0.6× 36 2.6× 16 278
Zheming Ruan United States 10 177 1.6× 100 1.9× 12 0.6× 7 0.4× 13 0.9× 17 260
Lawrence A. Vincent United States 8 98 0.9× 89 1.6× 18 0.9× 25 1.4× 5 0.4× 13 210
Yuri Bukhtiyarov United States 9 46 0.4× 118 2.2× 19 1.0× 18 1.0× 16 1.1× 17 179
Lori L. Bostrom United States 9 149 1.4× 107 2.0× 34 1.8× 15 0.8× 7 0.5× 10 332
Pratik Devasthale United States 8 87 0.8× 63 1.2× 17 0.9× 8 0.4× 35 2.5× 11 159
Yun Oliver Long United States 7 141 1.3× 66 1.2× 11 0.6× 16 0.9× 42 3.0× 12 198
Shawn D. Erickson United States 8 122 1.1× 96 1.8× 36 1.9× 10 0.6× 8 0.6× 10 236
Shari L. DeNinno United States 8 164 1.5× 128 2.4× 14 0.7× 54 3.0× 5 0.4× 8 242
Neil V. Harris United Kingdom 11 154 1.4× 118 2.2× 16 0.8× 19 1.1× 17 1.2× 15 280

Countries citing papers authored by Wen-Ching Han

Since Specialization
Citations

This map shows the geographic impact of Wen-Ching Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Ching Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Ching Han more than expected).

Fields of papers citing papers by Wen-Ching Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Ching Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Ching Han. The network helps show where Wen-Ching Han may publish in the future.

Co-authorship network of co-authors of Wen-Ching Han

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Ching Han. A scholar is included among the top collaborators of Wen-Ching Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Ching Han. Wen-Ching Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Fink, Brian E., Ashvinikumar V. Gavai, John S. Tokarski, et al.. (2006). Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3. Bioorganic & Medicinal Chemistry Letters. 16(6). 1532–1536. 36 indexed citations
2.
Hunt, John T., Toomas Mitt, R. M. Borzilleri, et al.. (2004). Discovery of the Pyrrolo[2,1-f][1,2,4]triazine Nucleus as a New Kinase Inhibitor Template. Journal of Medicinal Chemistry. 47(16). 4054–4059. 78 indexed citations
4.
Hall, Steven E., Wen-Ching Han, Harold Goldenberg, et al.. (1993). Synthesis of pyrrolidine oxazoles as thromboxane A2/endoperoxide receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 3(6). 1263–1266. 2 indexed citations
5.
Misra, Raj N., Philip M. Sher, Manorama M. Patel, et al.. (1992). Thromboxane receptor antagonist BMS-180291: A new pre-clinical lead. Bioorganic & Medicinal Chemistry Letters. 2(1). 73–76. 16 indexed citations
6.
Balasubramanian, Niranjan, Peter J. Brown, John D. Catt, et al.. (1989). A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase. Journal of Medicinal Chemistry. 32(9). 2038–2041. 24 indexed citations
7.
Avasthi, K., et al.. (1981). Reaction of dicarbonyl compounds with dimethyl 3-ketoglutarate. Influence of steric effects on success of the condensation. Tetrahedron Letters. 22(36). 3475–3478. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026